Story thread · 4 reports / 1 sources

Diodes anticipates Q3 revenue of about $510M with 35% gross margin as it advances proposed ElevATE deal

seekingalpha.com · 5dShare

First report: InfuSystem anticipates 6% to 8% annual revenue growth as wound care expands and adjusted EBITDA margin targets low to mid-20% — seekingalpha.com, 7d